262 related articles for article (PubMed ID: 31369907)
1. Iron and other metals in the pathogenesis of Parkinson's disease: Toxic effects and possible detoxification.
Bjørklund G; Hofer T; Nurchi VM; Aaseth J
J Inorg Biochem; 2019 Oct; 199():110717. PubMed ID: 31369907
[TBL] [Abstract][Full Text] [Related]
2. Metals and Parkinson's Disease: Mechanisms and Biochemical Processes.
Bjorklund G; Stejskal V; Urbina MA; Dadar M; Chirumbolo S; Mutter J
Curr Med Chem; 2018; 25(19):2198-2214. PubMed ID: 29189118
[TBL] [Abstract][Full Text] [Related]
3. Toxic Feedback Loop Involving Iron, Reactive Oxygen Species, α-Synuclein and Neuromelanin in Parkinson's Disease and Intervention with Turmeric.
Jansen van Rensburg Z; Abrahams S; Bardien S; Kenyon C
Mol Neurobiol; 2021 Nov; 58(11):5920-5936. PubMed ID: 34426907
[TBL] [Abstract][Full Text] [Related]
4. Iron as the concert master in the pathogenic orchestra playing in sporadic Parkinson's disease.
Riederer P; Monoranu C; Strobel S; Iordache T; Sian-Hülsmann J
J Neural Transm (Vienna); 2021 Oct; 128(10):1577-1598. PubMed ID: 34636961
[TBL] [Abstract][Full Text] [Related]
5. Targeting dysregulation of brain iron homeostasis in Parkinson's disease by iron chelators.
Weinreb O; Mandel S; Youdim MBH; Amit T
Free Radic Biol Med; 2013 Sep; 62():52-64. PubMed ID: 23376471
[TBL] [Abstract][Full Text] [Related]
6. Reprint of: revisiting oxidative stress and mitochondrial dysfunction in the pathogenesis of Parkinson disease-resemblance to the effect of amphetamine drugs of abuse.
Perfeito R; Cunha-Oliveira T; Rego AC
Free Radic Biol Med; 2013 Sep; 62():186-201. PubMed ID: 23743292
[TBL] [Abstract][Full Text] [Related]
7. Parkinson's disease and iron.
Mochizuki H; Choong CJ; Baba K
J Neural Transm (Vienna); 2020 Feb; 127(2):181-187. PubMed ID: 32025811
[TBL] [Abstract][Full Text] [Related]
8. The role of alpha-synuclein as ferrireductase in neurodegeneration associated with Parkinson's disease.
Sian-Hulsmann J; Riederer P
J Neural Transm (Vienna); 2020 May; 127(5):749-754. PubMed ID: 32318880
[TBL] [Abstract][Full Text] [Related]
9. The role of transition metals in the pathogenesis of Parkinson's disease.
Kienzl E; Puchinger L; Jellinger K; Linert W; Stachelberger H; Jameson RF
J Neurol Sci; 1995 Dec; 134 Suppl():69-78. PubMed ID: 8847547
[TBL] [Abstract][Full Text] [Related]
10. Iron and alpha-synuclein in the substantia nigra of MPTP-treated mice: effect of neuroprotective drugs R-apomorphine and green tea polyphenol (-)-epigallocatechin-3-gallate.
Mandel S; Maor G; Youdim MB
J Mol Neurosci; 2004; 24(3):401-16. PubMed ID: 15655262
[TBL] [Abstract][Full Text] [Related]
11. Metals, oxidative stress and neurodegenerative disorders.
Jomova K; Vondrakova D; Lawson M; Valko M
Mol Cell Biochem; 2010 Dec; 345(1-2):91-104. PubMed ID: 20730621
[TBL] [Abstract][Full Text] [Related]
12. In silico evidence for glutathione- and iron-related pathogeneses in Parkinson's disease.
Yeager MP; Coleman RA
J Neurosci Methods; 2010 Apr; 188(1):151-64. PubMed ID: 20144654
[TBL] [Abstract][Full Text] [Related]
13. The role of iron in neurodegeneration: prospects for pharmacotherapy of Parkinson's disease.
Jellinger KA
Drugs Aging; 1999 Feb; 14(2):115-40. PubMed ID: 10084365
[TBL] [Abstract][Full Text] [Related]
14. Alpha-synuclein: relating metals to structure, function and inhibition.
McDowall JS; Brown DR
Metallomics; 2016 Apr; 8(4):385-97. PubMed ID: 26864076
[TBL] [Abstract][Full Text] [Related]
15. What have we learnt from CDNA microarray gene expression studies about the role of iron in MPTP induced neurodegeneration and Parkinson's disease?
Youdim MB
J Neural Transm Suppl; 2003; (65):73-88. PubMed ID: 12946050
[TBL] [Abstract][Full Text] [Related]
16. The Pathopharmacological Interplay between Vanadium and Iron in Parkinson's Disease Models.
Ohiomokhare S; Olaolorun F; Ladagu A; Olopade F; Howes MR; Okello E; Olopade J; Chazot PL
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32937783
[TBL] [Abstract][Full Text] [Related]
17. Ferroptosis in Parkinson's disease: Molecular mechanisms and therapeutic potential.
Ding XS; Gao L; Han Z; Eleuteri S; Shi W; Shen Y; Song ZY; Su M; Yang Q; Qu Y; Simon DK; Wang XL; Wang B
Ageing Res Rev; 2023 Nov; 91():102077. PubMed ID: 37742785
[TBL] [Abstract][Full Text] [Related]
18. Genetics of iron regulation and the possible role of iron in Parkinson's disease.
Rhodes SL; Ritz B
Neurobiol Dis; 2008 Nov; 32(2):183-95. PubMed ID: 18675357
[TBL] [Abstract][Full Text] [Related]
19. The role of iron in senescence of dopaminergic neurons in Parkinson's disease.
Youdim MB; Riederer P
J Neural Transm Suppl; 1993; 40():57-67. PubMed ID: 8294901
[TBL] [Abstract][Full Text] [Related]
20. The Role of Xenobiotics and Trace Metals in Parkinson's Disease.
Bjørklund G; Dadar M; Chirumbolo S; Aaseth J
Mol Neurobiol; 2020 Mar; 57(3):1405-1417. PubMed ID: 31754997
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
